ID   FA98
AC   CVCL_IU81
DR   Cosmic; 2559134
DR   Wikidata; Q54833214
RX   PubMed=25653542;
CC   Doubling time: ~22 hours (PubMed=25653542).
CC   Donor information: Established from a chronic smoker. Treated prior to cell line establishment with erlotinib (PubMed=25653542).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 6
//
RX   PubMed=25653542; DOI=10.2147/OTT.S71242; PMCID=PMC4303463;
RA   Lam, David Chi-Leung
RA   Luo, Susan Y.
RA   Deng, Wen
RA   Kwan, Johnny Sheung-Him
RA   Rodriguez-Canales, Jaime
RA   Cheung, Annie Lai-Man
RA   Cheng, Grace H.-W.
RA   Lin, Chi-Ho
RA   Wistuba, Ignacio Ivan
RA   Sham, Pak Chung
RA   Wan, Thomas Shek-Kong
RA   Tsao, George Sai-Wah
RT   "Oncogenic mutation profiling in new lung cancer and mesothelioma cell
RT   lines.";
RL   Onco Targets Ther. 8:195-209(2015).
//